The study of the interaction between LINC00511 and EZH2, the catalytic subunit of PRC2, was a crucial step towards understanding the mechanisms through which LINC00511 exerted its oncogenic function in breast cancer. This evidence concerns the gene EZH2 and breast carcinoma.